Afuco™ Anti-Human IGF1 ADCC Therapeutic Antibody (BI 836845), ADCC Enhanced
Anti-IGF1 ADCC Enhanced Antibody (BI 836845) is an ADCC enhanced antibody produced by our Afuco™ platform. BI 836845 is a HumAb of the IgG1 isotype against the human insulin-like growth factors IGF-1 and IGF-2, which are up-regulated in many tumors. BI 836845 is well tolerated in patients with advanced solid tumours. An RBD of 1000 mg weekly was identified. An expansion phase is ongoing and recruiting patients with Ewing sarcoma or all tumor types with biopsiable disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-370CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IGF1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage |
|